6.Morales TG, Sampliner RE. Barrett's esophagus: update on screening, surveillance, and treatment.Arch Intern Med. 1999;159:1411-1416.[PubMed][DOI[ 7.Macdonald CE, Wicks AC, Playford RJ. Ten years' experience of screening patients with Barrett's oesophagus in a university teaching hospital...
Mucosal reactive oxygen species production in oesophagitis and Barrett's oesophagus. Gut. 1995;37:168-173. [PubMed] [DOI] [Cited in This Article: 1] [Cited by in Crossref: 77] [Cited by in F6Publishing: 86] [Article Influence: 3.0] [Reference Citation Analysis (0)] 3. Wetscher ...
Zooming in on Barrett Oesophagus Using Narrow-Band Imaging: An International Observer Agreement Study. Eur. J. Gastroenterol. Hepatol. 2009, 21, 1068. [Google Scholar] [CrossRef] [PubMed] Baldaque-Silva, F.; Marques, M.; Lunet, N.; Themudo, G.; Goda, K.; Toth, E.; Soares, J....
Confocal laser endomicroscopy for in vivo diagnosis of Barrett’s oesophagus and associated neoplasia: A pilot study conducted in a single Italian centre. Dig. Liver Dis. 2013, 45, 396–402. [Google Scholar] [CrossRef] [PubMed] Leggett, C.L.; Gorospe, E.C.; Chan, D.K.; Muppa, P...
Bile Acids in Combination with Low PH Induce Oxidative Stress and Oxidative DNA Damage: Relevance to the Pathogenesis of Barrett’s Oesophagus. Gut 2007, 56, 763–771. [Google Scholar] [CrossRef] [PubMed] [Green Version] Jiang, J.; Wakimoto, H.; Seidman, J.G.; Seidman, C.E. Allele...
Not all low grade dysplasia in Barrett’s oesophagus is the same: Using specific histological criteria in predicting progression to neoplasia. Pathology 2021, 53, 700–704. [Google Scholar] [CrossRef] Ten Kate, F.; Nieboer, D.; Ten Kate, F. Improved Progression Prediction in Barrett’s ...
Over the last two decades, endoscopic eradication therapy has been established as the therapeutic strategy of choice for patients with Barrett’s oesophagus-related dysplasia and early oesophageal adenocarcinoma. With a multimodal approach, ablative therapies have been highly effective in achieving remarkable...
Over the last two decades, endoscopic eradication therapy has been established as the therapeutic strategy of choice for patients with Barrett’s oesophagus-related dysplasia and early oesophageal adenocarcinoma. With a multimodal approach, ablative ther